Biocon Biologics partners with Civica to enhance access to Insulin Aspart in the US, no tech transfer involved.

Why it matters: More than 3.5 million Californians have diabetes, and insulin is a life-saving part of their disease ...

President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing ...

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

The study states that artificial sweeteners, also known as non-nutritive sweeteners, have long been used as a low-calorie ...

The US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood sugar levels. It calls the new drug “Merilog,” a biosimilar to the widely-used insulin ...

During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...

Tandem is following competitor Insulet’s lead with the second automated insulin delivery system indicated for Type 2 diabetes ...

The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.

Tandem Diabetes Care, Inc.’s Control-IQ+ Technology, used with the t:slim and Mobi insulin pumps, becomes the second AID ...

The story of one huge advance in health care shows why public investment in science is critical and why proposed cuts are ...